TY - JOUR
T1 - Effect of Salt Supplementation on Sympathetic Activity and Endothelial Function in Salt-Sensitive Type 2 Diabetes
AU - Baqar, Sara
AU - Kong, Yee Wen
AU - Chen, Angela X.
AU - O'Callaghan, Christopher
AU - MacIsaac, Richard J.
AU - Bouterakos, Maree
AU - Lambert, Gavin W.
AU - Jerums, George
AU - Lambert, Elisabeth E.
AU - Ekinci, Elif I.
PY - 2020/4
Y1 - 2020/4
N2 - Context: Lower sodium intake is paradoxically associated with higher mortality in type 2 diabetes (T2D). Objective: To determine whether sympathetic nervous system (SNS) activation and endothelial dysfunction contribute to these observations, we examined the effect of salt supplementation on these systems in people with T2D with habitual low sodium. We hypothesized that salt supplementation would lower SNS activity and improve endothelial function compared to placebo. Design: We conducted a randomized, double-blinded, placebo-controlled crossover trial. Setting: The study took place in a tertiary referral diabetes outpatient clinic. Participants: Twenty-two people with T2D with habitual low sodium intake (24-hour urine sodium <150 mmol/24h) were included. Intervention: Salt supplementation (100 mmol NaCl/24h) or placebo for 3 weeks was administered. Main outcome measures: The primary outcome of SNS activity and endothelial function was assessed as follows: Microneurography assessed muscle sympathetic nerve activity (MSNA), pulse amplitude tonometry assessed endothelial function via reactive hyperemic index (RHI), and arterial stiffness was assessed via augmentation index (AI). Secondary outcomes included cardiac baroreflex, serum aldosterone, ambulatory blood pressure monitoring (ABPM), heart rate variability (HRV), and salt sensitivity. Results: Compared to placebo, salt supplementation increased MSNA (burst frequency P =.047, burst incidence P =.016); however, RHI (P =.24), AI (P =.201), ABPM (systolic P =.09, diastolic P =.14), and HRV were unaffected. Salt supplementation improved baroreflex (slope P =.026) and lowered aldosterone (P =.004), and in salt-resistant individuals there was a trend toward improved RHI (P =.07). Conclusions: In people with T2D and low habitual sodium intake, salt supplementation increased SNS activity without altering endothelial function or blood pressure but improved baroreflex function, a predictor of cardiac mortality. Salt-resistant individuals trended toward improved endothelial function with salt supplementation.
AB - Context: Lower sodium intake is paradoxically associated with higher mortality in type 2 diabetes (T2D). Objective: To determine whether sympathetic nervous system (SNS) activation and endothelial dysfunction contribute to these observations, we examined the effect of salt supplementation on these systems in people with T2D with habitual low sodium. We hypothesized that salt supplementation would lower SNS activity and improve endothelial function compared to placebo. Design: We conducted a randomized, double-blinded, placebo-controlled crossover trial. Setting: The study took place in a tertiary referral diabetes outpatient clinic. Participants: Twenty-two people with T2D with habitual low sodium intake (24-hour urine sodium <150 mmol/24h) were included. Intervention: Salt supplementation (100 mmol NaCl/24h) or placebo for 3 weeks was administered. Main outcome measures: The primary outcome of SNS activity and endothelial function was assessed as follows: Microneurography assessed muscle sympathetic nerve activity (MSNA), pulse amplitude tonometry assessed endothelial function via reactive hyperemic index (RHI), and arterial stiffness was assessed via augmentation index (AI). Secondary outcomes included cardiac baroreflex, serum aldosterone, ambulatory blood pressure monitoring (ABPM), heart rate variability (HRV), and salt sensitivity. Results: Compared to placebo, salt supplementation increased MSNA (burst frequency P =.047, burst incidence P =.016); however, RHI (P =.24), AI (P =.201), ABPM (systolic P =.09, diastolic P =.14), and HRV were unaffected. Salt supplementation improved baroreflex (slope P =.026) and lowered aldosterone (P =.004), and in salt-resistant individuals there was a trend toward improved RHI (P =.07). Conclusions: In people with T2D and low habitual sodium intake, salt supplementation increased SNS activity without altering endothelial function or blood pressure but improved baroreflex function, a predictor of cardiac mortality. Salt-resistant individuals trended toward improved endothelial function with salt supplementation.
KW - 24-hour urinary sodium excretion
KW - Endothelial dysfunction
KW - Renin-angiotensin-aldosterone system
KW - Salt sensitivity
KW - Sympathetic nervous system
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85081945033&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgz219
DO - 10.1210/clinem/dgz219
M3 - Article
C2 - 31761946
AN - SCOPUS:85081945033
SN - 0021-972X
VL - 105
SP - E1187-E1200
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 4
ER -